Arcus Biosciences (RCUS) P/E (2018 - 2026)
Arcus Biosciences (RCUS) P/E from Apr 2, 2018 to Jun 3, 2026. The TTM Arcus Biosciences (RCUS) P/E is -5.70. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Arcus Biosciences (RCUS)
| Year | P/E | Change |
|---|---|---|
| 2026 | -5.70 | +0.12% |
| 2025 | -5.70 | +18.11% |
| 2024 | -4.82 | +0.22% |
| 2023 | -4.81 | -127.22% |
| 2022 | 17.68 | -67.25% |
| 2021 | 53.99 | -544.75% |
| 2020 | -12.14 | +123.35% |
| 2019 | -5.43 | -43.74% |
| 2018 | -9.66 | N/A |
Comparison Arcus Biosciences (RCUS) P/E with competitors
Arcus Biosciences (RCUS) P/E is -5.70.